Pathstone Holdings
DXCM icon

Pathstone Holdings’s DexCom DXCM Stock Holding History

Pathstone Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Buy
13,614
+269
+2% +$17.9K ﹤0.01% 1549
2026
Q1 		$838K Buy
13,345
+2,362
+22% +$164K ﹤0.01% 1493
2025
Q4 		$729K Sell
10,983
-36,768
-77% -$2.38M ﹤0.01% 1575
2025
Q3 		$3.21M Buy
47,751
+32,570
+215% +$2.58M 0.01% 763
2025
Q2 		$1.33M Sell
15,181
-284
-2% -$22.3K 0.01% 1240
2025
Q1 		$1.06M Buy
15,465
+197
+1% +$16.1K ﹤0.01% 1353
2024
Q4 		$1.19M Sell
15,268
-2,335
-13% -$173K 0.01% 1273
2024
Q3 		$1.18M Sell
17,603
-10,237
-37% -$841K 0.01% 1275
2024
Q2 		$3.16M Buy
27,840
+1,734
+7% +$219K 0.01% 708
2024
Q1 		$3.62M Buy
26,106
+217
+0.8% +$27.3K 0.02% 639
2023
Q4 		$3.21M Buy
+25,889
New +$2.64M 0.02% 562

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Pathstone Holdings's DXCM Position: Q2 2026 in Review

Pathstone Holdings increased its DexCom (DXCM) stake by 2% in Q2 2026, buying an estimated $17.9K and bringing the position to 13,614 shares worth $917K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Pathstone Holdings first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.62M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Pathstone Holdings held 13,614 shares of DexCom worth $917K as of Q2 2026.
  • Pathstone Holdings bought 269 DexCom shares in Q2 2026, an estimated $17.9K.
  • DexCom made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1549 holding.
  • Pathstone Holdings first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's DexCom position peaked at $3.62M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.